Work

"Recently Reported Dual-Drug Co-Delivery of Liposomal-Based Chemotherapeutics to Treat Breast Cancer"

Year: 2021

Type: article

Abstract: The use of nanocarriers such as liposomes to co-encapsulate more than one anticancer drug has been shown to be a promising strategy in cancer treatment with respect to overcoming multidrug resistance (MDR).This is in part not only due to the many advantages associated with the use of liposomes, but also the effectiveness of using this dual-drug strategy to overcome potential drug resistance when compared to a single chemotherapeutic.In this review, we report promising recently reported dualdrug co-delivery of liposomal-based chemotherapeutics in order to treat breast cancer and provide some perspectives on possible future constructs.

Source: Biomedical Journal of Scientific & Technical Research

DOI: 10.26717/bjstr.2021.39.006280

Author: David R Khan

Institution: West Texas A&M University

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: diamond

Funder: Welch Foundation